Content
Frontiers of Medicine >> 2023, Volume 17, Issue 1 doi: 10.1007/s11684-022-0934-1
CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer
Abstract
Keywords
osimertinib ; anti-CD47 antibody ; combination strategy ; ADCP ; EGFR
Content